▶ 調査レポート

世界の融合生検市場

• 英文タイトル:Global Market Study on Fusion Biopsy: Surge in prostate cancer incidences to propel the market revenue for fusion biopsy

Persistence Market Researchが調査・発行した産業分析レポートです。世界の融合生検市場 / Global Market Study on Fusion Biopsy: Surge in prostate cancer incidences to propel the market revenue for fusion biopsy / MRC2304I0168資料のイメージです。• レポートコード:MRC2304I0168
• 出版社/出版日:Persistence Market Research / 2023年1月26日
• レポート形態:英文、PDF、250ページ
• 納品方法:Eメール
• 産業分類:バイオ
• 販売価格(消費税別)
  Single User¥735,000 (USD4,900)▷ お問い合わせ
  Site Licence¥1,140,000 (USD7,600)▷ お問い合わせ
  Enterprisewide¥1,590,000 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社の本調査資料では、世界の融合生検市場について調査・分析を行い、市場の現状と今後の展望を整理しています。本書は、エグゼクティブサマリー、市場概要、市場リスク・動向分析、市場背景・基礎データポイント、主要成功要因、需要分析・予測、価値分析・予測、生検経路別(経会陰、経直腸)分析、エンドユーザー別(病院、診断センター、外来手術センター)分析、地域別(北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ)分析、市場構造分析、競争分析、仮定、調査手法など、以下の構成で掲載しています。また、MedCom、ESAOTE SPA、KOELIS、Focal Healthcare、GeoScan Medical、UC-Care Medical Systems Ltd.などの企業情報が含まれています。
・エグゼクティブサマリー
・市場概要
・市場リスク・動向分析
・市場背景・基礎データポイント
・主要成功要因
・需要分析・予測
・価値分析・予測
・世界の融合生検市場規模:生検経路別
- 経会陰における市場規模
- 経直腸における市場規模
・世界の融合生検市場規模:エンドユーザー別
- 病院における市場規模
- 診断センターにおける市場規模
- 外来手術センターにおける市場規模
・世界の融合生検市場規模:地域別
- 北米の融合生検市場規模
- 中南米の融合生検市場規模
- ヨーロッパの融合生検市場規模
- アジア太平洋の融合生検市場規模
- 中東・アフリカの融合生検市場規模
・市場構造分析
・競争分析
・仮定
・調査手法

Fusion Biopsy Market- Scope of Report

A recent study by PMR on the Fusion Biopsy Market offers a 10-year forecast for 2023 to 2033. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering Fusion Biopsy.

The study also provides the dynamics responsible for influencing the future status of the Fusion Biopsy market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies operating in the Fusion Biopsy market, along with their product portfolios, key strategies and SWOT analysis, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of Fusion Biopsy across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of Fusion Biopsy during the forecast period. Price point comparison by region with global average price is also considered in the study.

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of value (US$ Mn).

Estimates at global and regional levels for Fusion Biopsy and the Fusion Biopsy market are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a service provider can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global Fusion Biopsy Market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the Fusion Biopsy market during the forecast period.

Country-specific valuation on demand for Fusion Biopsy has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

In-depth Analysis on Competition

The report sheds light on leading players of Fusion Biopsy market along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering Fusion Biopsy has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the Fusion Biopsy domain.

レポート目次

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Persistence Market Research Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on Fusion Biopsy Demand

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background and Foundation Data Points

    4.1. Global Fusion Biopsy Market (US$ Mn)

    4.2. Fusion Biopsy Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors – Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Global Fusion Biopsy Market Growth

        4.5.3. Fusion Biopsy Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Fusion Biopsy Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking

6. Global Fusion Biopsy Market Demand Analysis 2018-2022 and Forecast, 2023-2033

    6.1. Historical Market Analysis, 2018-2022

    6.2. Current and Future Market Projections, 2023-2033

    6.3. Y-o-Y Growth Trend Analysis

7. Global Fusion Biopsy Market Value Analysis 2018-2022 and Forecast, 2023-2033

    7.1. Historical Market Value (US$ Mn) Analysis, 2018-2022

    7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Fusion Biopsy Market Analysis 2018-2022 and Forecast 2023-2033, By Biopsy Route

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Biopsy Route Technique, 2018-2022

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Biopsy Route Technique, 2023-2033

        8.3.1. Transperineal

        8.3.2. Transrectal

    8.4. Market Attractiveness Analysis By Biopsy Route Technique

9. Global Fusion Biopsy Market Analysis 2018-2022 and Forecast 2023-2033, By End-Use

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By End-Use, 2018-2022

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-Use, 2023-2033

        9.3.1. Hospitals

        9.3.2. Diagnostic Centers

        9.3.3. Ambulatory Surgery Centers

    9.4. Market Attractiveness Analysis By End-Use

10. Global Fusion Biopsy Market Analysis 2018-2022 and Forecast 2023-2033, By Region

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Analysis By Region, 2018-2022

    10.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2023-2033

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Europe

        10.3.4. Asia Pacific

        10.3.5. Middle East and Africa (MEA)

    10.4. Market Attractiveness Analysis By Region

11. North America Fusion Biopsy Market Analysis 2018-2022 and Forecast 2023-2033

    11.1. Introduction

    11.2. Pricing Analysis

    11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033

        11.4.1. By Country

            11.4.1.1. U.S.

            11.4.1.2. Canada

            11.4.1.3. Rest of North America

        11.4.2. By Biopsy Route Technique

        11.4.3. By End-Use

    11.5. Market Attractiveness Analysis

        11.5.1. By Country

        11.5.2. By Biopsy Route Technique

        11.5.3. By End-Use

12. Latin America Fusion Biopsy Market Analysis 2018-2022 and Forecast 2023-2033

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033

        12.4.1. By Country

            12.4.1.1. Brazil

            12.4.1.2. Mexico

            12.4.1.3. Rest of Latin America

        12.4.2. By Biopsy Route Technique

        12.4.3. By End-Use

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By Biopsy Route Technique

        12.5.3. By End-Use

13. Europe Fusion Biopsy Market Analysis 2018-2022 and Forecast 2023-2033

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033

        13.4.1. By Country

            13.4.1.1. Germany

            13.4.1.2.  France

            13.4.1.3. U.K.

            13.4.1.4. Italy

            13.4.1.5. Benelux

            13.4.1.6. Nordic Countries

            13.4.1.7. Rest of Europe

        13.4.2. By Biopsy Route Technique

        13.4.3. By End-Use

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Biopsy Route Technique

        13.5.3. By End-Use

14. Asia Pacific Fusion Biopsy Market Analysis 2018-2022 and Forecast 2023-2033

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033

        14.4.1. By Country

            14.4.1.1. China

            14.4.1.2. Japan

            14.4.1.3. South Korea

            14.4.1.4. Rest of Asia Pacific

        14.4.2. By Biopsy Route Technique

        14.4.3. By End-Use

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Biopsy Route Technique

        14.5.3. By End-Use

15. Middle East and Africa Fusion Biopsy Market Analysis 2018-2022 and Forecast 2023-2033

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033

        15.4.1. By Country

            15.4.1.1. GCC Countries

            15.4.1.2. South Africa

            15.4.1.3. Turkey

            15.4.1.4. Rest of Middle East and Africa

        15.4.2. By Biopsy Route Technique

        15.4.3. By End-Use

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Biopsy Route Technique

        15.5.3. By End-Use

16. Key Countries Fusion Biopsy Market Analysis 2018-2022 and Forecast 2023-2033

    16.1. Introduction

        16.1.1. Market Value Proportion Analysis, By Key Countries

        16.1.2. Global Vs. Country Growth Comparison

    16.2. US Fusion Biopsy Market Analysis

        16.2.1. Value Proportion Analysis by Market Taxonomy

        16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            16.2.2.1. By Biopsy Route Technique

            16.2.2.2. By End-Use

    16.3. Canada Fusion Biopsy Market Analysis

        16.3.1. Value Proportion Analysis by Market Taxonomy

        16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            16.3.2.1. By Biopsy Route Technique

            16.3.2.2. By End-Use

    16.4. Mexico Fusion Biopsy Market Analysis

        16.4.1. Value Proportion Analysis by Market Taxonomy

        16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            16.4.2.1. By Biopsy Route Technique

            16.4.2.2. By End-Use

    16.5. Brazil Fusion Biopsy Market Analysis

        16.5.1. Value Proportion Analysis by Market Taxonomy

        16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            16.5.2.1. By Biopsy Route Technique

            16.5.2.2. By End-Use

    16.6. Germany Fusion Biopsy Market Analysis

        16.6.1. Value Proportion Analysis by Market Taxonomy

        16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            16.6.2.1. By Biopsy Route Technique

            16.6.2.2. By End-Use

    16.7. France Fusion Biopsy Market Analysis

        16.7.1. Value Proportion Analysis by Market Taxonomy

        16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            16.7.2.1. By Biopsy Route Technique

            16.7.2.2. By End-Use

    16.8. Italy Fusion Biopsy Market Analysis

        16.8.1. Value Proportion Analysis by Market Taxonomy

        16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            16.8.2.1. By Biopsy Route Technique

            16.8.2.2. By End-Use

    16.9. BENELUX Fusion Biopsy Market Analysis

        16.9.1. Value Proportion Analysis by Market Taxonomy

        16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            16.9.2.1. By Biopsy Route Technique

            16.9.2.2. By End-Use

    16.10. UK Fusion Biopsy Market Analysis

        16.10.1. Value Proportion Analysis by Market Taxonomy

        16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            16.10.2.1. By Biopsy Route Technique

            16.10.2.2. By End-Use

    16.11. Nordic Countries Fusion Biopsy Market Analysis

        16.11.1. Value Proportion Analysis by Market Taxonomy

        16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            16.11.2.1. By Biopsy Route Technique

            16.11.2.2. By End-Use

    16.12. China Fusion Biopsy Market Analysis

        16.12.1. Value Proportion Analysis by Market Taxonomy

        16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            16.12.2.1. By Biopsy Route Technique

            16.12.2.2. By End-Use

    16.13. Japan Fusion Biopsy Market Analysis

        16.13.1. Value Proportion Analysis by Market Taxonomy

        16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            16.13.2.1. By Biopsy Route Technique

            16.13.2.2. By End-Use

    16.14. South Korea Fusion Biopsy Market Analysis

        16.14.1. Value Proportion Analysis by Market Taxonomy

        16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            16.14.2.1. By Biopsy Route Technique

            16.14.2.2. By End-Use

    16.15. GCC Countries Fusion Biopsy Market Analysis

        16.15.1. Value Proportion Analysis by Market Taxonomy

        16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            16.15.2.1. By Biopsy Route Technique

            16.15.2.2. By End-Use

    16.16. South Africa Fusion Biopsy Market Analysis

        16.16.1. Value Proportion Analysis by Market Taxonomy

        16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            16.16.2.1. By Biopsy Route Technique

            16.16.2.2. By End-Use

    16.17. Turkey Fusion Biopsy Market Analysis

        16.17.1. Value Proportion Analysis by Market Taxonomy

        16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            16.17.2.1. By Biopsy Route Technique

            16.17.2.2. By End-Use

        16.17.3. Competition Landscape and Player Concentration in the Country

17. Market Structure Analysis

    17.1. Market Analysis by Tier of Companies

    17.2. Market Concentration

    17.3. Market Share Analysis of Top Players

    17.4. Market Presence Analysis

        17.4.1. By Regional footprint of Players

        17.4.2. Product footprint by Players

18. Competition Analysis

    18.1. Competition Dashboard

    18.2. Competition Benchmarking

    18.3. Competition Deep Dive

        18.3.1. MedCom

            18.3.1.1. Overview

            18.3.1.2. Product Portfolio

            18.3.1.3. Sales Footprint

            18.3.1.4. Strategy Overview

        18.3.2. ESAOTE SPA

            18.3.2.1. Overview

            18.3.2.2. Product Portfolio

            18.3.2.3. Sales Footprint

            18.3.2.4. Strategy Overview

        18.3.3. KOELIS

            18.3.3.1. Overview

            18.3.3.2. Product Portfolio

            18.3.3.3. Sales Footprint

            18.3.3.4. Strategy Overview

        18.3.4. Focal Healthcare

            18.3.4.1. Overview

            18.3.4.2. Product Portfolio

            18.3.4.3. Sales Footprint

            18.3.4.4. Strategy Overview

        18.3.5. GeoScan Medical

            18.3.5.1. Overview

            18.3.5.2. Product Portfolio

            18.3.5.3. Sales Footprint

            18.3.5.4. Strategy Overview

        18.3.6. UC-Care Medical Systems Ltd.

            18.3.6.1. Overview

            18.3.6.2. Product Portfolio

            18.3.6.3. Sales Footprint

            18.3.6.4. Strategy Overview

19. Assumptions and Acronyms Used

20. Research Methodology